NCT00376259View on ClinicalTrials.gov

Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone

PHASE3TerminatedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

August 31, 2008

Conditions
Hepatitis B
Interventions
DRUG

telbivudine

600mg/day oral tablet for 96 weeks

DRUG

adefovir dipivoxil

10 mg of adefovir by mouth once daily

Trial Locations (6)

Unknown

Novartis, San Diego

San Mateo

Pok Fu Lam

Seoul

Novarits, Kaohsuing

Bangkok

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY